Regulated information

Get easy access to all the information you need. The documentation center allows you to open, send by e-mail or download any document. Feel free to use the filters and add several documents to your basket.

105 publications

Name	Date	Type
[VIDEO ]Présentation des résultats 2020 - french Présentation analystes & investisseurs - 1er avril 2021	01/04/2021	Annual Report
[VIDEO] Présentation des résultats semestriels 2021 - french Présentation analystes & investisseurs - 29 juillet 2021	29/07/2021	Half Year Report
[Video] Présentation des résultats semestriels 2022 - french Présentation analystes & investisseurs - 15 septembre 2022	29/07/2021	Half Year Report
2009 activity report	21/04/2010	Annual Report
2009 annual earnings March 31, 2010 – (Lure, France) – Vétoquinol’s Board of Directors, meeting on March 11, 2010, reviewed the Group’s business and approved its 2009 financial statements.	31/03/2010	Public releases
2009 Annual earnings 2009 Annual earnings	01/04/2010	Annual Report
2020 annual results 2020 sales: €427.5m (up 8.0% as reported) EBIT before depreciation of assets arising from acquisitions: €65.3m (up 33.5%) Net income - Group share: €19.2m (4.5% of sales) Cash flow: €92.2m	01/04/2021	Public releases
2020 sales: €427.5M (up 8.0% as reported, up 10.9% at constant exchange rate) essentials sales: €220.6M (up 15.7% as reported, up 17.3% at constant exchange rate) Vetoquinol CEO Matthieu Frechin said: “2020 was an exceptional year on a number of counts. Above all, it is important to pay tribute to our teams, whose hard work and exemplary dedication allowed us to manage the impact of the health crisis. Year on year, we achieved double-digit sales growth at constant exchange rates, driven by our Essentials products. This momentum accounts for additional sales of €43 million (at constant exchange rates). We also completed a major acquisition in the form of the Drontal® and Profender® product ranges, entailing three structural effects for Vetoquinol: a scale effect, a product mix effect in the Essentials range and potential extensions, the first of which has been confirmed in January 2021 for the Australian market. We are optimistic for our business outlook in 2021, while being vigilant in relation to the global sanitary situation.”	21/01/2021	Public releases
2020 Universal registration document 2020 universal registration document including the Annual Financial Report	28/04/2021	Reference document
2021 first half results 2021 Half year results	29/07/2021	Public releases